These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6462252)

  • 1. [Co-carcinogens of the initiation- (or tumor-) promoter type as cancer risk factors. A current problem of environmental carcinogenesis and experimental analysis of a typical etiologic model situation].
    Hecker E
    Naturwissenschaften; 1984 May; 71(5):259-61. PubMed ID: 6462252
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-carcinogens of the initiation-(or tumor)promoter type as environmental risk factors of cancer in man, experimental analysis of an etiologic model situation of life style cancer and current problems of assessment of cancer risk in multifactorial carcinogenesis.
    Hecker E
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():145-64. PubMed ID: 6385618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Co-carcinogens or modulators of carcinogenesis. New aspects of the etiology of human tumors and of the molecular mechanisms of carcinogenesis].
    Hecker E
    Naturwissenschaften; 1978 Dec; 65(12):640-8. PubMed ID: 740037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis.
    Kodell RL; Krewski D; Zielinski JM
    Risk Anal; 1991 Sep; 11(3):483-90. PubMed ID: 1947353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effects of metabolism of environmental agents on cancer tumor development by a two-stage model of carcinogenesis.
    Tan WY; Singh KP
    Environ Health Perspect; 1987 Oct; 74():203-10. PubMed ID: 3691427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocarcinogens of the tumour-promoter type as potential risk factors of cancer in man. A first complete experimental analysis of an etiological model situation and some of its consequences.
    Hecker E
    IARC Sci Publ; 1984; (56):441-63. PubMed ID: 6536607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hyperplasia in liver carcinogenesis.
    Mirsalis JC; Steinmetz KL
    Prog Clin Biol Res; 1990; 331():149-61. PubMed ID: 2179957
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene-amplification model of carcinogenesis.
    Pall ML
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2465-8. PubMed ID: 6941303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the initiation-promotion regimen in mouse skin relevant to complete carcinogenesis?
    Scribner JD; Scribner NK
    Carcinog Compr Surv; 1982; 7():13-8. PubMed ID: 6802488
    [No Abstract]   [Full Text] [Related]  

  • 10. [An experimental study of the promoting effects of extracts from Chinese medicinal herbs and tung oil (HHPA)].
    Sun Y
    Zhonghua Bing Li Xue Za Zhi; 1986 Mar; 15(1):9-11. PubMed ID: 2946439
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of promoters on incidence of bladder cancer in experimental animal models.
    Hicks RM
    Environ Health Perspect; 1983 Apr; 50():37-49. PubMed ID: 6873029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
    Stevens FJ; Peraino C
    Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
    [No Abstract]   [Full Text] [Related]  

  • 13. Multistage theory of carcinogenesis: the epidemiological evidence for liver cancer.
    Kaldor JM; Bosch FX
    Bull Cancer; 1990; 77(5):515-9. PubMed ID: 2400827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocarcinogenesis and biological effects of tumor promoters.
    Carcinog Compr Surv; 1982; 7():1-664. PubMed ID: 7066913
    [No Abstract]   [Full Text] [Related]  

  • 15. Cocarcinogenesis and biological effects of tumor promoters. Conclusions and perspectives.
    Cairns J
    Carcinog Compr Surv; 1982; 7():647-51. PubMed ID: 7066931
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoplastic transformation in the planarian: I. Cocarcinogenesis and histopathology.
    Hall F; Morita M; Best JB
    J Exp Zool; 1986 Nov; 240(2):211-27. PubMed ID: 3794621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of experimental chemical carcinogenesis and its applications to human cancer risk.
    Lijinsky W
    Cancer Res; 1979 Jul; 39(7 Pt 2):2887-90. PubMed ID: 376127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of multiple carcinogens and synergy index.
    Kawaguchi I; Doi M; Kakinuma S; Shimada Y
    J Theor Biol; 2006 Nov; 243(1):143-51. PubMed ID: 16860345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin grafting in the study of cocarcinogenesis.
    COWEN PN
    Br J Cancer; 1959 Jun; 13(2):228-35. PubMed ID: 13812489
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus-enhancing plant promoters in east Africa.
    Mizuno F; Osato T; Imai S; Koizumi S; Aya T; Kinoshita T; Hirai N; Hirota M; Ohigashi H; Koshimizu K
    AIDS Res; 1986 Dec; 2 Suppl 1():S151-5. PubMed ID: 3030344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.